Braunschweig, Germany

Steven Eschig

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2024.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Steven Eschig

Introduction

Steven Eschig is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of functionalized polymers. His work is characterized by a focus on innovative chemical compounds that have practical applications in various industries.

Latest Patents

Eschig holds a patent for a functionalized polymer that features at least one Diels-Alder adduct covalently bonded to it. This Diels-Alder adduct contains both a furan and a maleimide component. Notably, one of these components possesses a functional organyl group with a molar mass of less than 800 g/mol. This invention showcases his expertise in polymer chemistry and its potential applications.

Career Highlights

Steven Eschig is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to explore and develop innovative solutions in the field of applied research.

Collaborations

Eschig has collaborated with talented colleagues such as Stefan Friebel and Philipp Schmidt. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Steven Eschig's contributions to the field of functionalized polymers highlight his innovative spirit and dedication to research. His patent reflects a significant advancement in polymer chemistry, showcasing the potential for practical applications in various industries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…